Neurosense Announces Third Quarter 2022 Financial Results And Provides Business Update

Published on December 02, 2022 03:08 AM AEDT

Neurosense Announces Third Quarter 2022 Financial Results And Provides Business Update — Image source: ©2022 Kalkine Media®

Dec 1 (Reuters) - Neurosense Therapeutics Ltd:

* NEUROSENSE THERAPEUTICS LTD - 9-MONTH LOSS PER SHARE $0.80

* NEUROSENSE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* NEUROSENSE THERAPEUTICS LTD - AS OF SEPTEMBER 30, 2022, NEUROSENSE HAD CASH AND SHORT-TERM DEPOSITS OF $8.44 MILLION

* NEUROSENSE THERAPEUTICS LTD - BELIEVES THAT CASH RESOURCES WILL BE SUFFICIENT TO CONTINUE DEVELOPMENT OF CO'S PRODUCT INTO Q4 OF 2023 Further company coverage:

Reuters

Reuters -
96361 Posts
...

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.